Boca Biolistics

Executive Summary

Boca Biolistics, founded in 2004 and headquartered in Pompano Beach, Florida, is a private biospecimen and clinical research services company. The company operates a CAP- and CLIA-certified laboratory, offering a comprehensive suite of services including biobanking, custom biospecimen procurement, central laboratory testing, and end-to-end clinical trial support. Serving the diagnostics, proteomics, and pharmaceutical development sectors, Boca Biolistics has established itself as a reliable partner for biomarker discovery, assay development, and clinical trial logistics. With over two decades of operational history, the company benefits from a well-established infrastructure and a track record of supporting complex research programs. As the precision medicine and diagnostic markets continue to expand, Boca Biolistics is well-positioned to capitalize on increasing demand for high-quality biospecimens and centralized laboratory services. The company's focus on quality and compliance, underpinned by its CAP/CLIA accreditation, provides a competitive edge. However, being a private entity, Boca Biolistics does not disclose financial data, making it challenging to assess growth trajectory. The company's success hinges on its ability to secure new contracts with pharmaceutical and biotech sponsors, maintain its certifications, and adapt to evolving regulatory requirements in the clinical research landscape.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Laboratory Service Offerings70% success
• Q2 2027Strategic Partnership with a Major Pharma Sponsor50% success
• Q3 2026Renewal of CAP/CLIA Accreditation95% success